Fund factsheetFundFacts API
Issuer Bellevue Asset Management AGFigures as of 2026-10-02Generated 4 Oct 2026

Bellevue Medtech & Services B-EUR

LU0415391431UCITS Fund

The fund’s aim is to achieve capital growth in the long term, is actively managed and invests worldwide in companies active in the medical technology and healthcare services sector. Aim is to provide investors an attractive healthcare fund solution by investing in the entire healthcare universe with the exclusion of drug makers.

Growth of 100

80901002022202320242025
Fund94MSCI World IMI HC Equip. & Supplies90
2021-12 → 2025-12 · rebased to 100

Key facts

TER1.60%
Inception2009-09-28
Holdings43
CurrencyEUR

Top holdings

  1. 01Abbott Laboratories9.50%
  2. 02Intuitive Surgical9.40%
  3. 03Medtronic9.10%
  4. 04Dexcom5.00%
  5. 05Stryker4.80%
  6. 06Edwards Lifesciences4.80%
  7. 07Becton Dickinson4.10%
  8. 08Boston Scientific3.90%
  9. 09Hoya3.70%
  10. 10EssilorLuxottica3.70%

Sectors

28%Cardiology
  • Cardiology28.1%
  • Life Science Supply13.0%
  • Surgery9.8%
  • Managed Care8.1%
  • Other7.9%
  • Ophthalmology7.5%
  • Orthopedics7.0%
  • Other13.5%
  • 5.1% not disclosed

Countries

  1. United States83.2%
  2. Japan4.5%
  3. Switzerland4.2%
  4. France3.7%
  5. Germany1.9%
  6. Denmark1.5%
  7. Great Britain1.0%

Risk & profile

1
2
3
4
5
6
7
Lower risk · lower rewardHigher risk · higher reward
United States Equity
ConcentrationConcentratedRegionUnited StatesSectorBroad

Calendar-year returns

−12.0%2022+0.9%2023+15.3%2024−8.6%2025
Fund MSCI World IMI HC Equip. & Supplies

Annualised returns

PeriodFundIndexDiff
1 Year−15.54%−16.85%+1.31%
3 Years p.a.−5.41%−5.07%−0.34%
5 Years p.a.−2.17%−3.60%+1.43%
10 Years p.a.+6.59%+6.89%−0.30%
Since Inception+9.46%+11.26%−1.80%

Risk & valuation metrics

Volatility 3y14.9%
Sharpe 3y-0.45

Figures as of 2026-10-02. Data from FundFacts API; not investment advice.